Back to Search
MICHAEL HEINRICH, MD
MD
Hematology & Oncology Physician
NPI: 1548278005IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD14573(OR)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1984
Research & Publications (20)
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
PMID 18451237·Clin Cancer Res·2008
3-trial
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
PMID 18955458·J Clin Oncol·2008
3-trial
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
PMID 18955451·J Clin Oncol·2008
3-trial
Does tumor mutational status correlate with clinical response to imatinib?
PMID 17080176·Nat Clin Pract Oncol·2006
8-other
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
PMID 16505440·J Clin Oncol·2006
8-other
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.
PMID 16954519·J Clin Oncol·2006
3-trial
Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
PMID 15895440·J Surg Oncol·2005
6-review
Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects.
PMID 15032673·Mini Rev Med Chem·2004
6-review
Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
PMID 15217222·Cancer Treat Res·2004
6-review
Is KIT an important therapeutic target in small cell lung cancer?
PMID 14676102·Clin Cancer Res·2003
8-other
PDGFRA activating mutations in gastrointestinal stromal tumors.
PMID 12522257·Science·2003
7-preclinical
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.
PMID 14645423·J Clin Oncol·2003
3-trial
Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.
PMID 12094373·Hum Pathol·2002
6-review
Posttranscriptional cell cycle-dependent regulation of human FANCC expression.
PMID 10845936·Blood·2000
8-other
Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.
PMID 10910906·Blood·2000
8-other
Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources.
PMID 19505558·J Ethnopharmacol·2009
6-review
Intermolecular olefin functionalisation involving aryl radicals generated from arenediazonium salts.
PMID 19086045·Chemistry·2009
8-other
Self-report of headache in children and adolescents in Germany: possibilities and confines of questionnaire data for headache classification.
PMID 19250286·Cephalalgia·2009
8-other
Ethnopharmacological field studies: a critical assessment of their conceptual basis and methods.
PMID 19537298·J Ethnopharmacol·2009
6-review
Critical exponents for line tension and dipole density difference from lipid monolayer domain boundary fluctuations.
PMID 18598009·J Phys Chem B·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-6594
Quick Facts
- NPI
- 1548278005
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile